Farley J. Abad

Array ( [id] => 6063371 [patent_doc_number] => 20020031787 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-14 [patent_title] => 'Compositions and methods for reducing autoimmunity' [patent_app_type] => new [patent_app_number] => 09/775687 [patent_app_country] => US [patent_app_date] => 2001-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11356 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20020031787.pdf [firstpage_image] =>[orig_patent_app_number] => 09775687 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6908166 [patent_doc_number] => 20010010933 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-08-02 [patent_title] => 'Use of trans-activation and CIS-activation to modulate the persistence of expression of a transgene in an at least E4-deficient adenovirus' [patent_app_type] => new [patent_app_number] => 09/771832 [patent_app_country] => US [patent_app_date] => 2001-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10097 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20010010933.pdf [firstpage_image] =>[orig_patent_app_number] => 09771832 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6668365 [patent_doc_number] => 20030113348 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-19 [patent_title] => 'Virus strains' [patent_app_type] => new [patent_app_number] => 10/181692 [patent_app_country] => US [patent_app_date] => 2002-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10848 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20030113348.pdf [firstpage_image] =>[orig_patent_app_number] => 10181692 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6766341 [patent_doc_number] => 20030100741 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-29 [patent_title] => 'Nucleotide sequences encoding variable regions of heavy and light chains of monoclonal antibody 1F7, an anti-idiotypic antibody reactive with anti-HIV antibodies' [patent_app_type] => new [patent_app_number] => 09/759112 [patent_app_country] => US [patent_app_date] => 2001-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4124 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20030100741.pdf [firstpage_image] =>[orig_patent_app_number] => 09759112 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1279871 [patent_doc_number] => 06646110 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-11-11 [patent_title] => 'G-CSF polypeptides and conjugates' [patent_app_type] => B2 [patent_app_number] => 09/760008 [patent_app_country] => US [patent_app_date] => 2001-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 32013 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/646/06646110.pdf [firstpage_image] =>[orig_patent_app_number] => 09760008 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1360959 [patent_doc_number] => 06569684 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-05-27 [patent_title] => 'Method of identifying and treating invasive carcinomas' [patent_app_type] => B2 [patent_app_number] => 09/755811 [patent_app_country] => US [patent_app_date] => 2001-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 14 [patent_no_of_words] => 10109 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/569/06569684.pdf [firstpage_image] =>[orig_patent_app_number] => 09755811 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6947750 [patent_doc_number] => 20010021384 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-09-13 [patent_title] => 'Mucosally targeted immunization' [patent_app_type] => new [patent_app_number] => 09/746581 [patent_app_country] => US [patent_app_date] => 2000-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5973 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20010021384.pdf [firstpage_image] =>[orig_patent_app_number] => 09746581 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 716350 [patent_doc_number] => 07053179 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-05-30 [patent_title] => 'Five-Helix protein' [patent_app_type] => utility [patent_app_number] => 09/738945 [patent_app_country] => US [patent_app_date] => 2000-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 19 [patent_no_of_words] => 9189 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/053/07053179.pdf [firstpage_image] =>[orig_patent_app_number] => 09738945 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6720319 [patent_doc_number] => 20030054007 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-20 [patent_title] => 'Intracellular protein delivery compositions and methods of use' [patent_app_type] => new [patent_app_number] => 09/738046 [patent_app_country] => US [patent_app_date] => 2000-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9643 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20030054007.pdf [firstpage_image] =>[orig_patent_app_number] => 09738046 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1160412 [patent_doc_number] => 06759041 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-07-06 [patent_title] => 'Preventives/remedies for autoimmune demyelinating diseases' [patent_app_type] => B1 [patent_app_number] => 09/701486 [patent_app_country] => US [patent_app_date] => 2000-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6165 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/759/06759041.pdf [firstpage_image] =>[orig_patent_app_number] => 09701486 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1391593 [patent_doc_number] => 06548655 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-15 [patent_title] => 'Interleukin-4 receptors' [patent_app_type] => B1 [patent_app_number] => 09/724901 [patent_app_country] => US [patent_app_date] => 2000-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 31 [patent_no_of_words] => 24679 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/548/06548655.pdf [firstpage_image] =>[orig_patent_app_number] => 09724901 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1224534 [patent_doc_number] => 06699968 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-03-02 [patent_title] => 'Construction and use of synthetic constructs encoding syndecan' [patent_app_type] => B1 [patent_app_number] => 09/723677 [patent_app_country] => US [patent_app_date] => 2000-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 38807 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 141 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/699/06699968.pdf [firstpage_image] =>[orig_patent_app_number] => 09723677 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 627075 [patent_doc_number] => 07135458 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-11-14 [patent_title] => 'Interferon-γ inducing polypeptide, pharmaceutical composition thereof, monoclonal antibody thereto, and methods of use' [patent_app_type] => utility [patent_app_number] => 09/716356 [patent_app_country] => US [patent_app_date] => 2000-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 25426 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/135/07135458.pdf [firstpage_image] =>[orig_patent_app_number] => 09716356 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1342601 [patent_doc_number] => 06582689 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-24 [patent_title] => 'IL-18/IGIF chemotherapeutic compositions' [patent_app_type] => B1 [patent_app_number] => 09/700609 [patent_app_country] => US [patent_app_date] => 2000-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 23 [patent_no_of_words] => 9695 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/582/06582689.pdf [firstpage_image] =>[orig_patent_app_number] => 09700609 [rel_patent_id] =>[rel_patent_doc_number] =>)